IP Library Granted Patent US 8,337,755
Granted Patent B2
US 8,337,755 · App. 11/374,623 · Granted Dec 25, 2012

Operator independent programmable sample preparation and analysis system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,337,755
App. No.
11/374,623
Granted
Dec 25, 2012
Kind
B2
Abstract

The present invention provides a protocol and apparatus for enriching circulating tumor cells and other rare cells from blood, including debris and other components, from samples with high precision and at high throughput rates. This invention discloses an improved processing system from previously described semi-automated sample processing. The system further reduces operator intervention and hands-on time from prior systems. While this system has general utility in processing diverse materials, the system is configured for sample processing of biological specimens to provide an enriched fraction suitable for detection, enumeration and identification of target cells by appropriate analytical methodologies. The presence and quantities of such target cells in a sample specimen can utilized for screening and detection in disease such as cancer, assessing early stage pre-metastatic cancer, monitoring for disease remission in response to therapy and selection of more effective dose regimens or alternative therapies in case of relapse.

Claims (20)

1. A device for processing biological samples suspected to contain rare target bioentities comprising;

a. one or more carriers for receiving and transporting vessels containing said biological samples;

b. one or more carriers for receiving and transporting vessels containing reagents;

c. one or more vessels containing bulk system fluid;

d. one or more fluidic pumping means for manipulating said biological sample and said reagents wherein said pumping means has an aspiration rate between 120 ul/sec to 250 ul/sec to prevent damage to said rare target bioentites linked to paramagnetic particles;

e. one or more magnetic separators incorporating a tube rotation system

f. at least one magnetic incubator having a 70-degree tripole configuration; and

g. one or more programmable controlling means capable of storing and executing commands to control various system components wherein at least one command requires backfluid flushing when aspirating and dispensing said reagents.

2. The device of claim 1 , further comprising one or more electronic means capable of tracking reagent inventory.

3. The device of claim 1 , further comprising one or more electronic means capable of tracking reagent inventory.

4. The device of claim 1 , further comprising one or more electronic means for tracking sample identification.

5. The device of claim 1 , wherein said fluidic pumping means includes one or more non-magnetic alloy probes connected to a pump where said probes are positioned within said vessels using capacitive liquid level sensing and wherein said probes contain small air gaps when used in multiple pick-up methods.

6. The device of claim 5 , further comprising one or more washing means for washing said probes after contacting said biological sample or said reagents.

7. The device of claim 1 , wherein said magnetic separators create a holding force within said vessels containing said biological samples that is greater than shear forces experienced by aspiration of said biological sample from said magnetically collected target bioentity during processing.

8. The device of claim 7 , wherein said magnetic separators create a downward force in addition to said holding force in order to vertically concentrate said magnetically collected target bioentity.

9. The device of claim 8 , further comprising a means for rotating said vessels containing said biological samples while subjected to magnetic forces order to concentrate said magnetically collected target bioentity.

10. The device of claim 1 , wherein said magnetic separators create lateral forces capable of moving magnetically responsive entities through said biological sample.

11. The device of claim 10 , wherein moving said magnetically responsive entities through said biological sample enhances labeling of said entities

12. The device of claim 1 , wherein said target bioentites are selected from a group consisting of epithelial cells, tumor cells, endothelial cells, fungal cells, bacterial cells, cellular debri, cellular components, and combinations thereof.

13. The device of claim 1 , wherein said processing is in preparation of diagnostic image analysis, diagnostic nucleic acid analysis, and combinations thereof.

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded Jan 4, 2019
From: MENARINI SILICON BIOSYSTEMS, INC.
To: MENARINI SILICON BIOSYSTEMS S.P.A.
Reel/Frame 049631/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2018
From: JANSSEN DIAGNOSTICS, LLC
To: MENARINI SILICON BIOSYSTEMS, INC.
Reel/Frame 045238/0050 →
CHANGE OF NAME Recorded Dec 6, 2013
From: VERIDEX, LLC
To: JANSSEN DIAGNOSTICS, LLC
Reel/Frame 031970/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2008
From: IMMUNICON CORP.
To: VERIDEX, LLC
Reel/Frame 021334/0454 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2006
From: HOWARD, DAVE; LAPEUS, DAVE; KEENE, DOUGLAS; PAYNTER, DOUGLAS; RUTNER, HERMAN; MAYES, JARED; PROHASKA, JERRY; KAGAN, MICHAEL; BENDELE, TERESA; HARBART, THOMAS
To: IMMUNIVEST CORPORATION
Reel/Frame 017495/0401 →